Literature DB >> 27382207

Differential Expressions of p53, p53R2, hRRM2 and PBR in Chronic Lymphocytic Leukemia: A Correlation with Intracellular Cholesterol.

Ankit Verma1, N C Chandra2.   

Abstract

Regulation of intracellular cholesterol homeostasis exists under balance between intracellular biosynthesis and uptake from extracellular origin by cell surface transport proteins. Expected role of cholesterol on either tumor suppressor gene and/or DNA synthesis has been aimed in the present study to explore intracellular cholesterol homeostasis in CLL subjects. Higher expressions of p53R2 (p53 dependent subunit of ribonucleotide reductase) and p53 were found in lymphocytes of chronic human lymphocytic leukemia as comparison to their normal counterparts. Inverse relation was found with p53 independent R2 subunit (in human hRRM2) of ribonucleotide reductase, which was found to be decreased from its control group. More expression of peripheral type benzodiazepine receptor, a cholesterol transporter, was noticed in isolated nuclear fraction with simultaneous increase of cholesterol concentration in cytoplasmic and nuclear compartments. A parallel increase of cholesterol in cell nucleus with increased p53R2 expression shows priority of the involvement of cholesterol in the process of cell replication.

Entities:  

Keywords:  Chronic lymphocytic leukemia; hRRM2; p53; p53R2

Year:  2015        PMID: 27382207      PMCID: PMC4910855          DOI: 10.1007/s12291-015-0539-4

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  34 in total

1.  A new method for the direct determination of serum cholesterol.

Authors:  A ZLATKIS; B ZAK; A J BOYLE
Journal:  J Lab Clin Med       Date:  1953-03

Review 2.  Chronic lymphocytic leukemia.

Authors:  Nicholas Chiorazzi; Kanti R Rai; Manlio Ferrarini
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

3.  Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2.

Authors:  Y Chen; M Hughes-Fulford
Journal:  Int J Cancer       Date:  2001-01-01       Impact factor: 7.396

Review 4.  Receptor-mediated endocytosis: insights from the lipoprotein receptor system.

Authors:  M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

5.  A possible role of cholesterol-sphingomyelin/phosphatidylcholine in nuclear matrix during rat liver regeneration.

Authors:  Elisabetta Albi; Samuela Cataldi; Graziella Rossi; Mariapia Viola Magni
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

6.  Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol.

Authors:  M Hardwick; D Fertikh; M Culty; H Li; B Vidic; V Papadopoulos
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

Review 7.  The role of intranuclear lipids.

Authors:  E Albi; M P Viola Magni
Journal:  Biol Cell       Date:  2004-10       Impact factor: 4.458

8.  Benzodiazepines that bind at peripheral sites inhibit cell proliferation.

Authors:  J K Wang; J I Morgan; S Spector
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

9.  Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort.

Authors:  Tomer T Levin; Yuelin Li; John Riskind; Kanti Rai
Journal:  Gen Hosp Psychiatry       Date:  2007 May-Jun       Impact factor: 3.238

10.  Peripheral-type benzodiazepine receptor (PBR) gene amplification in MDA-MB-231 aggressive breast cancer cells.

Authors:  Matthew Hardwick; Luciane R Cavalli; Keith D Barlow; Bassem R Haddad; Vassilios Papadopoulos
Journal:  Cancer Genet Cytogenet       Date:  2002-11
View more
  1 in total

1.  Differential Response of B Cells to an Immunogen, a Mitogen and a Chemical Carcinogen in a Mouse Model System

Authors:  Nimisha Saxena; Amar Preet Kaur; Nimai Chand Chandra
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.